Health Condition 1: null- 2nd and 3rd trimester pregnent patients with white discharge per vagina
Conditions
Interventions
Intervention1: Group A: - Dhatakyadi Varti
: Group A
Drug Dhatakyadi Varti
Dose 3gm
Route Intra Vaginally(Posterior fornix)
Kala Once at bed time
Duration 14 days
Kala Once at bed time
Duration
Sponsors
Institute for Post Graduation Teaching and Research in Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 20 to 40 years with different parity 2. 2nd and 3rd Trimester of pregnancy 3. White discharge present during examination 4. Inflammation present in vulva and/or vagina 5. Micro-organisms present in vaginal discharge
Exclusion criteria
Exclusion criteria: 1. 1st Trimester of pregnancy 2. Age below 20 years or above 40 years with non-specific vulvovaginitis 2. Hypersensitivity to drug and inability to conform the protocol 3. Women with severe physical illness, any organic pathology, hepatic, cardiac, renal disease and any acute infection of any system 4. Women suffering from any systemic disease like Diabetes, T.B., S.T.Ds etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Screening of the antenatal patients attending the OPD of SRPT Dept IPGT And RA to elicit etiopathogenesis and prevalence of the condition of Upapluta Yonivyapad vulvovaginitis during pregnancyTimepoint: 1 Screening of the antenatal patients attending the OPD of SRPT Dept IPGT and RA to elicit etiopathogenesis and prevalence of the condition of Upapluta Yonivyapad vulvovaginitis during pregnancy | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess and compare the efficacy of both drugs Dhatakyadi Varti and Panchavalkaladi Varti in the management of Upapluta Yonivyapad (vulvovaginitis during pregnancy).Timepoint: 14 days | — |
Countries
India
Contacts
Public ContactProf L PDei
IPGT and RA GAU
Outcome results
None listed